Pancreatic Cancer Research

ResearcherAlbert Einstein College of MedicineActive in the last 2 years

Peter Muscarella Md

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1448-5507; OpenAlex author ID A5063034554. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 3 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 7

  1. Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2. Co-author DOI 10.1093/oncolo/oyae178↗
  2. Pancreatic Cancer Surgery Following Emergency Department Admission: Understanding Poor Outcomes and Disparities in Care. Co-author DOI 10.1007/s11605-020-04614-6↗
  3. Biomarkers as predictors of recurrence following curative resection for pancreatic ductal adenocarcinoma: a review. Last author DOI 10.1155/2014/468959↗
  4. BMS-911543 inhibits viability of tumor and stromal cells and limits disease progression in genetically engineered mice with pancreatic cancer Co-author DOI 10.1186/2051-1426-2-s3-p186↗
  5. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. Co-author DOI 10.6004/jnccn.2014.0106↗
  6. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. Co-author DOI 10.6004/jnccn.2012.0073↗
  7. Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease. Co-author DOI 10.1245/s10434-010-1397-1↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hassan A. Hatoum · 1 shared paper, 2024 · strength 0.18
  2. Barish H. Edil · 1 shared paper, 2024 · strength 0.18
  3. Emmanuel E. Zervos · 1 shared paper, 2024 · strength 0.18
  4. Ramtin Agah · 1 shared paper, 2024 · strength 0.18
  5. Alexander S. Rosemurgy · 1 shared paper, 2024 · strength 0.18
  6. John Christopher McAuliffe · 1 shared paper, 2021 · strength 0.17
  7. Vishes V. Mehta · 1 shared paper, 2021 · strength 0.17
  8. Haejin In · 1 shared paper, 2021 · strength 0.17
  9. Mark Bloomston · 3 shared papers, 2011–2014 · strength 0.12
  10. Edwin Christopher Ellison · 2 shared papers, 2011–2014 · strength 0.08
  11. Tanios Bekaii‐Saab · 2 shared papers, 2011–2014 · strength 0.06
  12. Sylvester N. Osayi · 1 shared paper, 2014 · strength 0.06
  13. Albert C. Koong · 2 shared papers, 2012–2014 · strength 0.05
  14. William G. Hawkins · 2 shared papers, 2012–2014 · strength 0.05
  15. Andrew H. Ko · 2 shared papers, 2012–2014 · strength 0.05
  16. Deborah A. Freedman-Cass · 2 shared papers, 2012–2014 · strength 0.05
  17. Martha B. Pitman · 2 shared papers, 2012–2014 · strength 0.05
  18. Brian G. Czito · 2 shared papers, 2012–2014 · strength 0.05
  19. John Parker Hoffman · 2 shared papers, 2012–2014 · strength 0.05
  20. Robert A. Wolff · 2 shared papers, 2012–2014 · strength 0.05
  21. Joseph M. Herman · 2 shared papers, 2012–2014 · strength 0.05
  22. Stephen W. Behrman · 2 shared papers, 2012–2014 · strength 0.05
  23. Eric K. Nakakura · 2 shared papers, 2012–2014 · strength 0.05
  24. Mokenge Peter Malafa · 2 shared papers, 2012–2014 · strength 0.05
  25. Sarah P. Thayer · 2 shared papers, 2012–2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.